Home New - Cardio Diagnostics
Enable data-driven multi-stakeholder collaborations among patients, innovative providers, health plans, employers, and governmental entities to drive transformative results in heart disease prevention and intervention. Innovative providers can improve patient outcomes by scaling evidence-based integrated epigenetic-genetic heart disease risk stratification initiatives. Savvy employers can protect employee productivity by investing in preventative care. The test can be completed at home via telehealth or in traditional provider settings and does not require patients to fast. We believe that prevention and early detection should be the norm, and that epigenetics-based technologies driven by artificial intelligence will unlock a new era of precision cardiovascular medicine that can help save lives and significantly cut unnecessary treatment costs. Our team is made up of subject matter experts with deep expertise in cardiovascular disease prevention, clinical testing, artificial intelligence, and engineering.
This company is:
Verified
Era of Telehealth: Innovative Solutions for Assessment of Cardiovascular Disease - Cardio Diagnostics
Written by: Ibani Kapur Medically reviewed by: Rob Philibert MD PhD “Virtual” or telemedicine healthcare visits have become the new norm for many patients. Telehealth (TH), which includes health services provided through telecommunication and digital technologies, is a form of virtual healthcare. TH is not restricted to one type of service and includes several types […]
Verified
How to Set Heart Healthy New Year’s Resolutions - and Keep Them! - Cardio Diagnostics
Use the Power of SMART Goal Setting Written by: Emily Lind Medically reviewed by: Rob Philibert, MD PhD New Year’s Resolutions are a popular way to kickstart goal setting. Some of the most common resolutions are to exercise more, lose weight, and quit smoking. Other resolutions, like learning a new skill or hobby, living […]
Verified
Mana Capital Acquisition Corp. Announces Closing of $62 Million Initial Public Offering - Cardio Diagnostics
DOVER, Del. – Mana Capital Acquisition Corp. (Nasdaq: MAAQU) (“Mana” or the “Company”), a newly incorporated blank check company, today announced the closing of its initial public offering. The offering was priced at $10.00 per unit, resulting in gross proceeds of $62,000,000. The Company’s units commenced trading on The Nasdaq Global Market under the ticker […]
View all products
Keywords
Industries
Where is Cardio Diagnostics located?
The company Cardio Diagnostics is located in Coralville, Iowa, United States. It's worth noting that the company may has more corporate locations
How many employees does Cardio Diagnostics approximately have?
As of the latest available information Cardio Diagnostics has around 1-10 employees worldwide.
When was Cardio Diagnostics founded?
Cardio Diagnostics was founded in 2017
In which industries does Cardio Diagnostics mainly work?
The company Cardio Diagnostics has it's main focus in the industries of Science and Engineering, Biotechnology, Health Care
Nexus Laboratories, LLC
United States
2013
CardioPhoenix
Canada
11-50 Employees
2010
GENinCode
United Kingdom
11-50 Employees
2018
Wise IOT Solutions
United States
1-10 Employees
Lifetime Sciences
United States
11-50 Employees
2015
National Imaging Associates
United States
1-10 Employees
1995
PGXL Laboratories
United States
11-50 Employees
2005
Extra Health BioTech
Canada
11-50 Employees
Topics which have been searched by others and may be interesting for you:
